Zortress Related Clinical Trials
A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer [Recruiting]
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis [Recruiting]
A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer [Recruiting]
Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer [Recruiting]
Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma [Recruiting]
Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer [Recruiting]
Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC [Recruiting]
Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer [Recruiting]
Study of RAD001 (Everolimus) for Children With NF1 and Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas [Recruiting]
Dose Finding Study of RAD001 (Everolimus, Afinitor�) in Combination With BEZ235 in Patients With Advanced Solid Tumors [Recruiting]
Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer [Recruiting]
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) [Recruiting]
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma [Recruiting]
Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC) [Recruiting]
Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane [Not yet recruiting]
A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers [Recruiting]
Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia [Recruiting]
STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell Lymphoma [Not yet recruiting]
Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex [Not yet recruiting]
Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC) [Recruiting]
Erlotinib and Temsirolimus for Solid Tumors [Recruiting]
Sirolimus as Therapeutic Approach to Uveitis [Recruiting]
Sirolimus for Autoimmune Disease of Blood Cells [Recruiting]
Anakinra or Denosumab and Everolimus in Advanced Cancer [Recruiting]
A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer [Recruiting]
Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant Recipients [Recruiting]
Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients [Recruiting]
Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer [Recruiting]
|
